
Regardless of the pulmonary disorder, the goal is to avoid hypoxemia, which can result in profound adverse maternal and fetal effects. Women who have cystic fibrosis or pulmonary lymphangioleiomyomatosis often experience a decline in pulmonary function during pregnancy, while those with sarcoidosis may show improvement. The mortality rate is 50% to 60% within 1 hour of the onset of symptoms. Women with amniotic fluid embolism typically present with sudden dyspnea and hypotension. Low molecular weight heparin is a safe and effective alternative to unfractionated heparin. AFE is a medical emergency that requires prompt treatment. Amniotic fluid embolism (AFE) is a rare disorder that affects between 1 in 8,000 to 1 in 80,000 pregnancies.

Early recognition and prompt treatment can save lives. Heparin is the treatment of choice for PE, and prophylactic heparin is indicated for women who had PE during a previous pregnancy. Amniotic fluid embolism is a rare, life threatening disorder affecting labor and childbirth. Regardless of the pulmonary disorder, the goal is to avoid hypoxemia, which can result in profound adverse maternal and fetal effects.ĪB - Pulmonary embolism (PE) and amniotic fluid embolism are uncommon complications during pregnancy, but they nonetheless require rapid diagnosis and treatment because of their high mortality rates.


Heparin is the treatment of choice for PE, and prophylactic heparin is indicated for women who had PE during a previous pregnancy. N2 - Pulmonary embolism (PE) and amniotic fluid embolism are uncommon complications during pregnancy, but they nonetheless require rapid diagnosis and treatment because of their high mortality rates. T1 - Pulmonary complications in pregnancy
